SCHEMBL2654413

SCHEMBL2654413

O=C(O)C1(c2ccc(F)cc2C2CCCCC2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PTGDR2 Q9Y5Y4 3/20 0.51
▸ CYP3A4 P08684 3/20 0.46
▸ PTGDR Q13258 1/20 0.41
▸ PTPRB P23467 1/20 0.39
▸ HDAC4 P56524 2/20 0.38
▸ APP P05067 2/20 0.37
▸ CYP2C9 P11712 2/20 0.37
▸ CYP2C19 P33261 2/20 0.37
▸ HSD11B1 P28845 1/20 0.37
▸ CYP2D6 P10635 1/20 0.37
▸ OPRL1 P41146 2/20 0.37
▸ F2RL1 P55085 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ NPC1 O15118 3/20 0.35
▸ RAB9A P51151 3/20 0.35
▸ POLB P06746 1/20 0.35
▸ MEN1 O00255 1/20 0.35
▸ GAA P10253 1/20 0.35
▸ KMT2A Q03164 1/20 0.35
▸ SMN1; SMN2 Q16637 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2653490 0.83 CYP3A4 (0.41) PTGDR2CYP3A4PTGDRMEN1KMT2A
SCHEMBL2653194 0.81 CYP3A4 (0.39) PTGDR2CYP3A4PTGDR
SCHEMBL2655512 0.80 PTGDR2 (0.55) PTGDR2CYP3A4NPC1RAB9AMEN1
SCHEMBL2653280 0.79 PTGS2 (0.44) CYP3A4PTGDRMEN1KMT2A
SCHEMBL2652827 0.77 PTGS2 (0.42) CYP3A4PTGDRMEN1KMT2A
SCHEMBL10418115 0.76 AKR1C1 (0.51) PTGDR2CYP3A4HDAC4HSD11B1MEN1
SCHEMBL2652798 0.76 ALDH1A1 (0.42) CYP3A4POLBMEN1KMT2ASMN1; SMN2
SCHEMBL2653810 0.75 PTGDR2 (0.46) PTGDR2PTGDRPTPRBOPRL1F2RL1
SCHEMBL2793934 0.75 APP (0.48) CYP3A4HDAC4APPCYP2C9CYP2C19
SCHEMBL2652919 0.74 CNR2 (0.36) PTGDR2CYP3A4NPC1RAB9APOLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1585739-A1 SUBSTITUTED ARYLCYCLOPROPYLACETAMIDES AS GLUCOKINASE ACTIVATORS ELI LILLY AND COMPANY (US) 2005-10-19 — — EP disclosed
WO-2004063179-A1 SUBSTITUTED ARYLCYCLOPROPYLACETAMIDES AS GLUCOKINASE ACTIVATORS ELI LILLY AND COMPANY (US) 2004-07-29 — — WO disclosed
Send feedback